Highlighter is on. Drag to highlight text. Click a highlight to remove it.
ALL / Pharmacology

Tacrolimus

Tacrolimus

Tacrolimus is a calcineurin inhibitor used as an immunosuppressant to prevent transplant rejection. It has a very similar action to ciclosporin.

Mechanism of action
  • decreases clonal proliferation of T cells by reducing IL-2 release
  • binds to FKBP forming a complex which inhibits calcineurin, a phosphotase that activates various transcription factors in T cells
    • this contrasts with ciclosporin, which binds to cyclophilin rather than FKBP

Adverse effects
  • nephrotoxicity (impaired renal function, raised creatinine) – dose-related and very common
  • neurotoxicity (tremor, headache, paraesthesia, seizures in severe cases)
  • hypertension
  • hyperglycaemia / diabetes mellitus (post-transplant diabetes)
  • hyperkalaemia

Tacrolimus is more potent than ciclosporin and hence the incidence of organ rejection is less. However, nephrotoxicity and impaired glucose tolerance is more common.
+PassMedicine Notes

Tacrolimus is a calcineurin inhibitor used as an immunosuppressant to prevent transplant rejection. It has a very similar action to ciclosporin.

Mechanism of action
  • decreases clonal proliferation of T cells by reducing IL-2 release
  • binds to FKBP forming a complex which inhibits calcineurin, a phosphotase that activates various transcription factors in T cells
    • this contrasts with ciclosporin, which binds to cyclophilin rather than FKBP
Adverse effects
  • nephrotoxicity (impaired renal function, raised creatinine) – dose-related and very common
  • neurotoxicity (tremor, headache, paraesthesia, seizures in severe cases)
  • hypertension
  • hyperglycaemia / diabetes mellitus (post-transplant diabetes)
  • hyperkalaemia

Tacrolimus is more potent than ciclosporin and hence the incidence of organ rejection is less. However, nephrotoxicity and impaired glucose tolerance is more common.



Saved ✓

MEDIA